Sung-Sun Cho

Director Ejecutivo en YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. .

68 años

Health Technology

Finance

Perfil

Sung-Sun Cho is currently the Chief Executive Officer and Director at Yuanta 4 SPECIAL PURPOSE ACQUISITION Co., Ltd.
Prior to this, Mr. Cho was the Chief Executive Officer at ProCell Therapeutics, Inc.

Cargos activos de Sung-Sun Cho

Empresas	Cargo	Inicio
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.	Director Ejecutivo	-

Todos los cargos activos de Sung-Sun Cho

Antiguos cargos conocidos de Sung-Sun Cho.

Empresas	Cargo	Fin
ProCell Therapeutics, Inc. ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea.	Director Ejecutivo	-

Ver el detalle de la experiencia de Sung-Sun Cho.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Sung-Sun Cho.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.	Finance

Empresas privadas	1
ProCell Therapeutics, Inc. ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea.	Health Technology